Form 8-K - Current report:
SEC Accession No. 0000950170-25-017075
Filing Date
2025-02-10
Accepted
2025-02-10 16:14:23
Documents
13
Period of Report
2025-02-10
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qttb-20250210.htm   iXBRL 8-K 49269
2 EX-99.1 qttb-ex99_1.htm EX-99.1 25524
3 GRAPHIC img38152436_0.jpg GRAPHIC 4813
  Complete submission text file 0000950170-25-017075.txt   203021

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250210.xsd EX-101.SCH 25023
15 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250210_htm.xml XML 4727
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 25605905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)